BSE filing, NSE: BRAWN. Summary written from the filing by ALFA Finder's alert engine.
Brawn Biotech Ltd: key numbers
- Share price
- ₹23.16
- Market cap
- ₹6.95 Cr
- Revenue (annual)
- ₹16.98 Cr
- Net profit (annual)
- ₹0.94 Cr
- P/E (TTM)
- 8.1×Sector 37.9×
- Promoter holding
- 52.94%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Brawn Biotech Ltd
All →Brawn Biotech Q2 FY27 Results: Net Profit ₹0 Cr
Brawn Biotech Ltd reported revenue from operations of ₹5.6 Cr (+14.3% YoY) and net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr
Brawn Biotech Board Meeting Date
Brawn Biotech intimated a board meeting on 05 Nov 2026 to consider un-audited Q2 FY27 results. The trading window stays closed till 16 Nov 2026.
Brawn Biotech Other Announcement
Brawn Biotech Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026. The filing includes details on promoter and public shareholding.
Brawn Biotech Other Announcement
Brawn Biotech Ltd members approved the appointment of M/s. GDSM and Co. as Statutory Auditors. Mr. Brij Raj Gupta was also re-appointed as Director at the Annual General Meeting.
Brawn Biotech Annual General Meeting
Brawn Biotech Ltd held its 41st Annual General Meeting on September 29, 2026. All resolutions were passed by the shareholders with the requisite majority.
Brawn Biotech Other Announcement
Brawn Biotech informed the exchange that it has issued letters to shareholders regarding the 41st AGM notice and annual report access.
Other other announcement announcements
All →Rubicon Research Other Announcement
Rubicon Research filed the India Ratings monitoring agency report for the IPO fresh issue proceeds for the quarter ended September 30, 2026. The agency found no deviation from the stated objects of the issue.
Priority Jewels Other Announcement
Priority Jewels filed CARE Ratings' monitoring agency report for the quarter ended September 2026. It flags pre-IPO proceeds used for general corporate purposes before the disclosure was made.
LEAP India Other Announcement
LEAP India uploaded its Key Performance Indicators from the August 11, 2026 prospectus to its website. The filing itself provides no new financial figures.
Poly Medicure Other Announcement
Poly Medicure's board revised five governance policies and codes, including material subsidiary, materiality, related party transactions, and insider trading codes. The revised documents are published on the company website.
Sumeet Industries Other Announcement
Sumeet Industries filed a Crisil monitoring agency report on its rights issue proceeds for the quarter ended September 30, 2026. The report flags a 10-25% deviation from stated objects, reallocating Rs 3,600 million approved by shareholders.
Ushanti Colour Chem Other Announcement
Ushanti Colour Chem reported its half-year utilisation of preferential issue proceeds. The funds were fully utilised with no deviation from stated objects.